Detalhe da pesquisa
1.
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax.
Br J Haematol
; 203(4): e98-e101, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533098
2.
Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia.
Hematol Oncol
; 27(4): 198-202, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19475701
3.
Feasibility of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia.
Leuk Lymphoma
; 47(8): 1593-8, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16966271
4.
High-dose cytarabine as consolidation treatment for patients with acute myeloid leukemia with t(8;21).
Leuk Res
; 26(6): 539-43, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12007501
5.
Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma.
Hematol J
; 5(3): 222-6, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15167908
6.
Ifosfamide, epirubicin and etoposide (IEV) regimen as salvage and mobilization therapy for refractory or early relapsing patients with aggressive non-Hodgkin's lymphoma.
Leuk Lymphoma
; 45(8): 1605-9, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15370212
7.
FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype.
Am J Hematol
; 84(8): 532-5, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19562748
8.
Age has no influence on mobilization of peripheral blood stem cells in acute myeloid leukemia.
Hematol Oncol
; 25(2): 84-9, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17361983
9.
Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation.
Hematol Oncol
; 24(2): 73-7, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16550628
10.
Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myeloma.
Ann Hematol
; 85(6): 394-9, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16538502
11.
Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia.
Eur J Haematol
; 71(1): 23-8, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12801295
12.
Conservative treatment for patients over 80 years with acute myelogenous leukemia.
Am J Hematol
; 71(4): 256-9, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12447953